Wei Cheng
Impact in
- Molecular Biology top 5%
- RNA modifications and cancer
- Inflammasome and immune disorders
- Plant Reproductive Biology
- Cancer-related gene regulation
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- CRISPR and Genetic Engineering 5
- Advanced biosensing and bioanalysis techniques 4
- Bacterial biofilms and quorum sensing 3
- Epidemiology 13
- Influenza Virus Research Studies 8
- Co-authors
- Jijie Chai (5 shared papers)Jinjing Wang (7 shared papers)Weikai Li (2 shared papers)Zhifu Han (2 shared papers)Junbiao Chang (2 shared papers)Xiao‐Tao Zeng (4 shared papers)Weizhu Yan (5 shared papers)Yanhui Zheng (3 shared papers)
- Journals
- Nature Communications (5 papers)Signal Transduction and Targeted Therapy (3 papers)PLoS ONE (2 papers)Frontiers in Public Health (2 papers)International Journal of Infectious Diseases (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Cheng
80 papers receiving 2.9k citations
Wei Cheng's Hit Papers
Peers
Comparison fields: 5 of 146
- Molecular Biology 1.5k
- Infectious Diseases 383
- Molecular Medicine 80
- Plant Science 581
- Immunology 289
Countries citing papers authored by Wei Cheng
This map shows the geographic impact of Wei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cheng more than expected).
Fields of papers citing papers by Wei Cheng
This network shows the impact of papers produced by Wei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cheng. The network helps show where Wei Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 344 | |
| 2 | 2011 | 336 | |
| 3 | 2015 | 254 | |
| 4 | 2020 | 218 | |
| 5 | Structural biology of SARS-CoV-2: open the door for novel therapies Hit paper breakdown → | 2022 | 194 |
| 6 | 2022 | 138 | |
| 7 | 2014 | 127 | |
| 8 | 2011 | 113 | |
| 9 | 2019 | 78 | |
| 10 | 2022 | 64 | |
| 11 | 2021 | 56 | |
| 12 | 2020 | 54 | |
| 13 | 2016 | 52 | |
| 14 | 2018 | 43 | |
| 15 | 2014 | 40 | |
| 16 | 2012 | 38 | |
| 17 | 2007 | 37 | |
| 18 | 2014 | 34 | |
| 19 | 2004 | 33 | |
| 20 | 2021 | 31 |
About Wei Cheng
Wei Cheng is a scholar working on Molecular Biology, Epidemiology, Genetics, Infectious Diseases and Ecology, having authored 86 papers that have together received 2.9k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (8 papers), Enzyme Structure and Function (6 papers), Bacterial Genetics and Biotechnology (5 papers), Bacteriophages and microbial interactions (5 papers), CRISPR and Genetic Engineering (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Bacterial biofilms and quorum sensing (3 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Infectious Diseases (383 citations), Molecular Medicine (80 citations), Plant Science (581 citations) and Immunology (289 citations). Wei Cheng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jijie Chai, Jinjing Wang, Weikai Li, Zhifu Han, Junbiao Chang, Xiao‐Tao Zeng, Weizhu Yan, Yanhui Zheng, Bin He and Tianhui Niu. Their work appears in journals such as Nature Communications, Signal Transduction and Targeted Therapy, PLoS ONE, Frontiers in Public Health and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.